NEX Health Intelligence secures €1M pre-seed to combat healthcare-associated infections with AI.
The AMW Read
Incremental update: early-stage Health AI company in a known player map, with no structural forces implicated.
NEX Health Intelligence secures €1M pre-seed to combat healthcare-associated infections with AI.
London-based NEX Health Intelligence has raised €1 million in pre-seed funding led by Brighteye Ventures, with participation from Adeline Arts & Science, AFI Ventures, and others. The company’s AI-powered infection intelligence platform helps hospitals detect, predict, and prevent healthcare-associated infections before they spread. Founded by Dr Ashleigh Myall after his NHS COVID-19 experience, the platform has already supported infection safety across over 40,000 patient admissions internationally, including deployments with NHS trusts in London and a military hospital in Southeast Asia.
Why it matters: Healthcare-associated infections affect a significant portion of hospital patients, driving longer stays and rising costs. NEX’s platform applies AI to a high-cost, high-impact clinical challenge, fitting the pattern of vertical AI adoption in regulated industries where domain-specific models can create defensible moats. The pre-seed round signals early investor appetite for AI-native infection control solutions, though the €1M raise is modest compared to later-stage health AI funding rounds. The company’s focus on clinical evidence and regulatory work in live hospital settings parallels the cautious, evidence-first approach seen in AI diagnostics startups.
Grounded expert take: NEX Health Intelligence addresses a clear operational pain point in hospitals — infection spread — using AI. Its early traction with NHS and international hospitals suggests product-market fit in a market where procurement is slow but sticky once trust is built. The €1M pre-seed is typical for a vertical AI startup at this stage; the key next step will be generating clinical and economic evidence to unlock larger contracts and Series A funding. The company’s trajectory aligns with the broader trend of AI moving from frontier models to targeted, domain-specific applications in healthcare.
#NEXHealth #HospitalInfection #AIinHealthcare #HealthTech #InfectionPrevention #BrighteyeVentures